journal article·2012

Bifunctional bacterial magnetic nanoparticles for tumor targeting

Lin Guo, Ji Huang, Li-Min Zheng

Nanoscale· Volume 4· Issue 3
Publisher page

Abstract

Bifunctional bacterial magnetic nanoparticles (BBMPs), which present both magnetic drug targeting and tumor bio-targeting properties, have been developed by chemically coupling both doxorubicin and a galactosyl ligand on to the membrane surface of the bacterial magnetic nanoparticles (BMPs). The BBMP product has a high drug load ratio and magnetic respondence, and exhibits a narrow size distribution and is sensitive to pH to enable drug release. In comparison to doxorubicin-coupled BMPs, without modification with a galactosyl ligand, BBMPs present a higher uptake by the target asialoglycoprotein receptor (ASGP-R) expressed by HepG2 cells and display stronger cytotoxicity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Cancer Research and Treatments · Bacteriophages and microbial interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (32)

Show source-provided references
1. Alexiou · Cancer Res. · 2000 · 60 · 6641
2. Babincova · Med. Phys. · 2004 · 31 · 221910.1118/1.1767101 ↗
3. Zhang · Pharm. Res. · 2005 · 22 · 57310.1007/s11095-005-2496-8 ↗
4. Kohler · Small · 2006 · 2 · 78510.1002/smll.200600009 ↗
5. Mejías · J. Controlled Release · 2008 · 130 · 16810.1016/j.jconrel.2008.05.028 ↗
6. Alexiou · Eur. Biophys. J. · 2006 · 35 · 44610.1007/s00249-006-0042-1 ↗
7. Son · J. Am. Chem. Soc. · 2005 · 127 · 731610.1021/ja0517365 ↗
8. Jain · Mol. Pharmaceutics · 2005 · 2 · 19410.1021/mp0500014 ↗
9. Gaihrea · Int. J. Pharm. · 2009 · 365 · 18010.1016/j.ijpharm.2008.08.020 ↗
10. Allen · Science · 2004 · 303 · 181810.1126/science.1095833 ↗
11. Peer · Nat. Nanotechnol. · 2007 · 2 · 75110.1038/nnano.2007.387 ↗
12. Xie · J. Am. Chem. Soc. · 2008 · 130 · 754210.1021/ja802003h ↗
13. Park · Clin. Cancer Res. · 2002 · 8 · 1172
14. Toublan · J. Am. Chem. Soc. · 2006 · 128 · 347210.1021/ja0544455 ↗
15. Huang · Adv. Funct. Mater. · 2007 · 17 · 229110.1002/adfm.200600818 ↗
16. Lippert · Proc. Natl. Acad. Sci. U. S. A. · 2008 · 105 · 1759510.1073/pnas.0809839105 ↗
17. Scheffel · Nature · 2006 · 440 · 11010.1038/nature04382 ↗
18. Bäuerlein · Angew. Chem., Int. Ed. · 2003 · 42 · 61410.1002/anie.200390176 ↗
19. Matsunaga · Appl. Microbio. Biotech. · 1987 · 26 · 32810.1007/BF00256663 ↗
20. Yoza · J. Biotechnol. · 2003 · 101 · 21910.1016/S0168-1656(02)00342-5 ↗
21. Tanaka · J. Biotechnol. · 2004 · 108 · 15310.1016/j.jbiotec.2003.11.010 ↗
22. Banerjee · Adv. Mater. · 2005 · 17 · 112810.1002/adma.200400724 ↗
23. Bharde · J. Am. Chem. Soc. · 2005 · 127 · 932610.1021/ja0508469 ↗
24. Guo · J. Mater. Chem. · 2008 · 18 · 599310.1039/b808556k ↗
25. Stefanoa · Eur. J. Pharm. Sci. · 2007 · 30 · 13610.1016/j.ejps.2006.10.012 ↗
26. Schwartz · J. Biol. Chem. · 1981 · 256 · 887810.1016/S0021-9258(19)52477-2 ↗
27. Wong · Eur. J. Pharm. Biopharm. · 2007 · 65 · 30010.1016/j.ejpb.2006.10.022 ↗
28. Du · Bioconjugate Chem. · 2008 · 19 · 249210.1021/bc800396h ↗
29. Guo · Biomaterials · 2009 · 30 · 188110.1016/j.biomaterials.2008.12.042 ↗
30. Hu · J. Controlled Release · 2007 · 118 · 710.1016/j.jconrel.2006.11.028 ↗
31. H Cho · Nat. Nanotechnol. · 2011 · 6 · 67510.1038/nnano.2011.149 ↗
32. Nasongkla · Nano Lett. · 2006 · 6 · 242710.1021/nl061412u ↗